Help Cancer Patients Find Bone Marrow Donors!

by Advita Fund USA
Help Cancer Patients Find Bone Marrow Donors!
Help Cancer Patients Find Bone Marrow Donors!
Help Cancer Patients Find Bone Marrow Donors!
Help Cancer Patients Find Bone Marrow Donors!
Help Cancer Patients Find Bone Marrow Donors!
Help Cancer Patients Find Bone Marrow Donors!
Help Cancer Patients Find Bone Marrow Donors!
Help Cancer Patients Find Bone Marrow Donors!
Help Cancer Patients Find Bone Marrow Donors!
Help Cancer Patients Find Bone Marrow Donors!
Help Cancer Patients Find Bone Marrow Donors!
Help Cancer Patients Find Bone Marrow Donors!
Help Cancer Patients Find Bone Marrow Donors!
Help Cancer Patients Find Bone Marrow Donors!
Help Cancer Patients Find Bone Marrow Donors!
Help Cancer Patients Find Bone Marrow Donors!
Help Cancer Patients Find Bone Marrow Donors!
Help Cancer Patients Find Bone Marrow Donors!
Help Cancer Patients Find Bone Marrow Donors!
Help Cancer Patients Find Bone Marrow Donors!
Help Cancer Patients Find Bone Marrow Donors!
Help Cancer Patients Find Bone Marrow Donors!

Project Report | Sep 24, 2024
Help Al-Ansar access lifesaving treatment!

By Marina | Project Leader

Al-Ansar is a 3-year-old boy from Kazakhstan.  In summer 2024 he was diagnosed with leukemia after falling ill.  The news was a shock to his parents, who took him to Turkey to verify the diagnosis.  Unfortunately, it was confirmed, and in addition, further classified as high-risk due to the presence of genetic dislocations.  High-risk leukemia patients are typically referred for bone marrow transplantation to prevent disease recurrence and resulting resistance to medications.  However, Kazakhstan is still in early stages of developing its own bone marrow donor registry, training its personnel to perform bone marrow transplantations and providing quality patient care. For these reasons many parents choose to take their children for treatment in nearby countries, such as Turkey, to ensure their kids have access to modern cancer care. 

Al-Ansar's parents brought him to a hospital in Antalya where he began undergoing chemotherapy.  Once he achieves remission,  he will need to undergo bone marrow transplant - either from one of his parents, or an unrelated donor, if a matching one can be found.  He has a long road ahead of him, and the treatment will be costly.  Our project was able to support Al-Ansar thanks to your donations, and his family is very grateful!  We are hopeful that he will overcome leukemia and return to normal happy chilhood like other kids of his age.  Thank you so much for your support of our project!  We hope you choose to donate again to patients like Al-Ansar and other brave kids who need our help!

Share on Twitter Share on Facebook

Jun 4, 2024
Support for little Akhmad

By Marina | Project Leader

Feb 8, 2024
You are helping Insur defeat lymphoma!

By Marina | Project Leader

About Project Reports

Project reports on GlobalGiving are posted directly to globalgiving.org by Project Leaders as they are completed, generally every 3-4 months. To protect the integrity of these documents, GlobalGiving does not alter them; therefore you may find some language or formatting issues.

If you donate to this project or have donated to this project, you can receive an email when this project posts a report. You can also subscribe for reports without donating.

Sign up for updates

Organization Information

Advita Fund USA

Location: Houston, Texas - USA
Website:
Facebook: Facebook Page
Twitter: @advitausa
Project Leader:
Marina Ouano
President
Houston , TX United States

Learn more about GlobalGiving

Teenage Science Students
Vetting +
Due Diligence

Snorkeler
Our
Impact

Woman Holding a Gift Card
Give
Gift Cards

Young Girl with a Bicycle
GlobalGiving
Guarantee

Get incredible stories, promotions, and matching offers in your inbox

WARNING: Javascript is currently disabled or is not available in your browser. GlobalGiving makes extensive use of Javascript and will not function properly with Javascript disabled. Please enable Javascript and refresh this page.